Progress in Clinical Research in Brazil: New ANVISA Regulations
This update aims to make Brazil an even more attractive environment for investment in clinical research and to strengthen the health innovation ecosystem.
Anvisa publishes panels on Dossier Adequacy Letter for Active Pharmaceutical Ingredients
This tool allows users to check and follow up on documents issued, as well as consult the analysis queue for these records.
Anvisa updates form for importing Cannabis-derived products
Anvisa has announced an update to the import form for Cannabis-derived products via express shipment, used in the Solicita system for individuals importing products for personal use.
Modified the list of medicines with suspended exports
They update the list of medicines with suspended exports in order to normalize the supply of critical and exceptional products.
DGAV clarifies the use of biocides in the food sector
The DGAV updates rules and obligations on biocides for food sector operators and explains the consequences of non-compliance.
Anvisa simplifies registration and entry of Mpox vaccines
Anvisa simplifies the registration and importation of Mpox vaccines, speeding up access and allowing registration to be waived.
INFARMED changes medicines for export
INFARMED updates the list of medicines and implements detailed rules for prior notification before export.
INFARMED changes prices with new homogeneous groups
INFARMED updates list of Homogeneous Groups and prices for the 3rd quarter of 2024, ensuring accessibility.
European Commission examines Falsified Medicines Directive
European Commission publishes detailed report and strengthens safety rules to improve the fight against falsified medicines.
Supervision of medicines in Spain gains recognition
GMP inspection services of AEMPS and Autonomous Communities gain international recognition after JAP audit.
